PlatformQ Health Presents Two E-Poster Presentations for the 80th Scientific Session of the American Diabetes Association

PlatformQ Health is thrilled to share two e-poster presentations that will be exhibited at the 80th Scientific Session of the American Diabetes Association (ADA). This virtual meeting commences Friday, June 12th and attendees can access all the presentations and posters on their own time at ADA’s website, diabetes.org. All the content that is normally available […]

Read More

PlatformQ Health and Leading Medical Partners Present Comprehensive and Diverse Mix of Online Education Programs in June

PlatformQ Health is excited to announce an influx of upcoming June programs including both accredited online healthcare provider activities and patient education sessions produced in collaboration with some of the leading aligned professional organizations, centers of excellence and patient advocacy groups. Despite recent travel and in-person meeting restrictions due to COVID-19, the PlatformQ Health production […]

Read More

American Society of Preventive Cardiology and Joslin Diabetes Center Partner with PlatformQ Health Education to Present a New CME

Delivering Trustworthy, Actionable Digital Continuing Medical Education, Together.   PlatformQ Health Education is excited to present Dyslipidemia, Diabetes, And Cardiovascular Risk: Clinical Strategies and Evolving Treatments, a free online CME session produced in partnership with the American Society for Preventive Cariology and accredited by the Joslin Diabetes Center (JOS). The program will air live on two […]

Read More

hATTR Amyloidosis CME

Overview of hATTR Amyloidosis: New CME

Join our experts for a one-hour CME presentation as they appraise clinical safety and efficacy data for new and emerging therapeutic agents for the treatment of hATTR amyloidosis.    hATTR amyloidosis is a genetic disorder that is characterized by the deposition of amyloid (abnormal proteins) in multiple organs. It often affects the nerves, liver, heart […]

Read More

Heart Failure CME

Expert-led Roundtable on Heart Failure: Part 2 Airs Live on February 9

On February 9, 2018 at 10:00 am EST, join CardioCareLive for a roundtable discussion on the new guidelines for the treatment of heart failure. In this second part of our series on Implementing Guideline-Directed Medical Therapy for Patients with Heart Failure, the panelists will discuss multidisciplinary approaches to implementing the guidelines – specifically, the challenges […]

Read More

Heart Failure Rates

Congestive Heart Failure 2016

Our understanding of congestive heart failure has been rapidly evolving over the past decade.  Heart failure is a leading cause of mortality globally and in the US. It is the final end-point of various cardiac diseases.  When the cardiac muscles fail, hypertrophy of the cardiac muscle cells is commonly observed. This hypertrophy of cardiomyoctes is […]

Read More

Heart

PCSK9 Inhibitors and Their Role in Lipid Management

The discovery of the relationship between lipids and cardiovascular disease was first made in the 1960s. Following this, an urgent need was filled by the founding of lipid lowering medications, with statins being the gold standard of therapy. However, the consequences of lipid disorders and cardiovascular disease remain prevalent despite this knowledge. Patients with familial […]

Read More

Clinical Spotlight on Novel Treatments for Heart Failure

Editor’s note: This article on new treatment options for heart failure also applies to HCPs caring for patients living with diabetes. Our sister site, CardioCareLive.com, hosted this online CME session.  In the United States there are about 5.7 million people diagnosed with heart failure (HF), most of them female. With 870,000 new HF patients diagnosed annually, the 2012 […]

Read More